Veri Medtech (VRHI) Retains PCAOB Auditor
Veri Medtech Holdings (VRHI) has announced the retention of Salberg & Company, P.A. as its PCAOB auditor on April 28, 2025. This strategic move is part of the company's uplisting process, as stated by CEO Sam Adetunji, who emphasized the company's mission to become the leading provider of healthcare technology services and products globally.
Veri Medtech Holdings (VRHI) ha annunciato la conferma di Salberg & Company, P.A. come suo revisore PCAOB il 28 aprile 2025. Questa mossa strategica fa parte del processo di quotazione superiore dell'azienda, come dichiarato dall'amministratore delegato Sam Adetunji, che ha sottolineato la missione dell'azienda di diventare il principale fornitore globale di servizi e prodotti tecnologici per la sanità.
Veri Medtech Holdings (VRHI) ha anunciado la contratación de Salberg & Company, P.A. como su auditor PCAOB para el 28 de abril de 2025. Este movimiento estratégico forma parte del proceso de ascenso en la bolsa de la compañía, según declaró el CEO Sam Adetunji, quien destacó la misión de la empresa de convertirse en el principal proveedor global de servicios y productos tecnológicos para la salud.
Veri Medtech Holdings (VRHI)는 2025년 4월 28일자로 Salberg & Company, P.A.를 PCAOB 감사인으로 선정했다고 발표했습니다. 이 전략적 결정은 회사의 상장 등급 상향 과정의 일환으로, CEO Sam Adetunji는 회사가 전 세계적으로 의료 기술 서비스 및 제품의 선도 공급자가 되는 것을 목표로 하고 있다고 강조했습니다.
Veri Medtech Holdings (VRHI) a annoncé le maintien de Salberg & Company, P.A. en tant qu’auditeur PCAOB à compter du 28 avril 2025. Cette décision stratégique s’inscrit dans le cadre du processus d’augmentation de la cotation de l’entreprise, comme l’a indiqué le PDG Sam Adetunji, qui a souligné la mission de la société de devenir le principal fournisseur mondial de services et produits technologiques dans le domaine de la santé.
Veri Medtech Holdings (VRHI) hat die Beibehaltung von Salberg & Company, P.A. als PCAOB-Prüfer zum 28. April 2025 bekannt gegeben. Dieser strategische Schritt ist Teil des Uplisting-Prozesses des Unternehmens, wie CEO Sam Adetunji erklärte, der die Mission des Unternehmens betonte, weltweit führender Anbieter von Gesundheitstechnologie-Dienstleistungen und -Produkten zu werden.
- Strategic move toward uplisting to a major exchange
- Appointment of PCAOB-registered auditor indicates commitment to higher financial reporting standards
- Currently trading on OTC Markets, indicating lower tier exchange listing
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings, Inc. (OTC Markets: (“VRHI”) ("Veri Medtech") announced today that it has retained Salberg & Company, P.A., as its PCAOB auditor, in furtherance of the uplisting process. For more information, please visit: http://www.salbergco.com.
"Veri Medtech (VRHI) continues to execute on its mission to be the premier provider of healthcare technology services and products worldwide. Retaining Salberg & Company is an important strategic next step in the company's steady upward trajectory to higher ground," said Sam Adetunji, CEO, Veri Medtech Holdings.
About Salberg & Company: SEC and PCAOB Compliant Financial Statement Audits and Reviews. Our firm serves a niche by providing SEC and PCAOB compliant financial statement audits and quarterly reviews, and audit related services such as audits to small and medium size publicly held companies throughout the United States. Salberg & Company's extensive experience with SEC matters and affiliations with securities attorneys, investment bankers and underwriters allows for a comprehensive quality service in the SEC arena that is unmatched for our client market. Our firm is registered with the Public Company Accounting Oversight Board (PCAOB). For more information, please visit: http://www.salbergco.com.
About Veri Medtech (OTC Markets: VRHI): Veri Medtech is a publicly-traded healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a strong integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models. With a commitment to innovation and patient-centric care, Veri MedTech continues to expand its services and reach, aiming to make personalized healthcare more accessible and effective for all. For more information, please visit: www.VeriMedTech.com
ABOUT ("PCAOB") PUBLIC COMPANY ACCOUNTING OVERSIGHT BOARD
The Public Company Accounting Oversight Board (PCAOB) is a private-sector, nonprofit corporation created by the Sarbanes-Oxley Act of 2002 to oversee the audits of public companies and other issuers in order to protect the interests of investors and further the public interest in the preparation of informative, accurate and independent audit reports.
Forward Looking Statements: Cautionary Note Regarding Forward-Looking Statements: This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Veri Medtech (OTC: "VRHI") and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
Press Release Inquiries: pr@verimedtech.com
FAQ
What is the significance of VRHI retaining a PCAOB auditor for uplisting?
When did Veri Medtech (VRHI) announce its PCAOB auditor appointment?
Which auditing firm has VRHI retained for its uplisting process?
What are VRHI's strategic goals according to the announcement?
